A Study to Evaluate Safety and Efficacy of YM178 in Patients With Overactive Bladder

Summary

The purpose of the study is to evaluate the effect of YM178 in patients with overactive bladder for 12-week administration.

Timeline

Start

2009-07-24

Primary completion

2010-02-15

Completion

2010-02-15

Publications

• Stoniute A, Madhuvrata P, Still M, Barron-Millar E, Nabi G, Omar MI. Oral anticholinergic drugs versus placebo or no treatment for managing overactive bladder syndrome in adults. Cochrane Database Syst Rev. 2023 May 9;5(5):CD003781. doi: 10.1002/14651858.CD003781.pub3.

Drugs

Indications